Merck and Eisai announced termination of a phase III trial of pembrolizumab plus lenvatinib (Lenvima) and transarterial chemoembolization (TACE) for unresectable liver cancer after an interim analysis ...

Soft tissue sarcomas (STS) are rare malignant tumors arising from connective tissues such as muscle, fat, and blood vessels, ...

Cancer patients who got an mRNA COVID vaccine within a few months of their immunotherapy lived longer than those who did not, health records show.

The use of immunotherapy in patients with various types of cancer has led to dramatic increases in survival. Increased median ...

Dr. Watson’s address distilled critical lessons into three actionable takeaways for individuals navigating the healthcare ...

It is now day 29 of the government shutdown and federal employees across the nation are feeling the impact of no pay, but one ...

In todays health check Dr. Samid Farooqui Pulmonologist and Clinic Manager Samantha Williams with Saint Anthony Hospital explains the warning signs of Lung cancer and how it can be prevented.

In the quest for more targeted lung cancer treatments, a researcher at the University of Missouri thinks the solution may lie in tiny bubble-shaped packages that cells use to talk to each other.

Phase III trial evaluating eftilagimod alfa (efti) in first line non-small cell lung cancer continues to build momentum and ...

Researchers have discovered a new genetic link to the most common type of bone cancer among children and young ...

The study, published in the journal Nature, showed the jabs provided an immunity boost that helped extend survival for certain skin and lung cancers.